NIH-backed researchers at Oregon Health & Science University (OHSU) introduced scSurvival, an AI model that forecasts cancer survival using single-cell tumor analysis. The tool is built to translate granular cellular data into patient-level prognostic risk, targeting a core challenge in oncology—reliably extracting clinically actionable meaning from single-cell heterogeneity. According to OHSU, scSurvival uses machine learning to analyze single-cell molecular patterns and map them to survival outcomes, aiming to improve stratification beyond bulk signals. The work adds to the growing shift toward computational biomarkers that can be validated across cohorts. For biotech developers, scSurvival represents another step toward more precise companion diagnostic-style analytics built from routine multiomic readouts, potentially accelerating trial design and response-risk modeling.